New Zealand markets closed

Microbot Medical Inc. (MBOT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.7800-0.0200 (-0.42%)
At close: 04:00PM EDT
4.7800 0.00 (0.00%)
After hours: 04:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.8000
Bid4.4000 x 900
Ask5.5000 x 900
Day's range4.7600 - 4.8870
52-week range4.3100 - 9.6000
Avg. volume10,300
Market cap33.977M
Beta (5Y monthly)3.56
PE ratio (TTM)N/A
EPS (TTM)-1.7040
Earnings date14 Nov 2022 - 18 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Microbot Medical Attracts Another Leading Physician and Expands Capabilities of its Scientific Advisory Board with Addition of Dr. Ripal Gandhi

    Miami-based Physician Specializes in Minimally Invasive Treatments for Peripheral Vascular Disease, Cancer, and Other Diseases HINGHAM, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), continuing its recent success of strengthening its Scientific Advisory Board with the recent recruitment of Key Opinion Leaders (KOLs), today announced that Ripal T. Gandhi, MD, FSVM, will join the Company’s robust Scientific Advisory Board (SAB). Dr. Gandhi is an interventional onco

  • GlobeNewswire

    Microbot Medical Enhances its Scientific Advisory Board (SAB) with its Newest Member Dr. Vincent Vidal

    Prominent France based interventional radiologist to leverage his expertise to assist the Company to achieve its future objective for the LIBERTY® Robotic SystemHINGHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to build a network of global leaders in the endovascular interventional space for the LIBERTY® Robotic System, today announced that Vincent Vidal, M.D., PhD, has joined its Scientific Advisory Board (SAB). Dr. Vidal is a world-leading

  • GlobeNewswire

    Microbot Medical to Review Recent Progress During H.C. Wainwright’s 24th Annual Global Investment Conference

    Company Continues to Achieve Primary Objectives for its LIBERTY® Robotic System in 2022HINGHAM, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that Harel Gadot, Chairman, President and CEO, will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference being held in NYC. Mr. Gadot will provide an overview of the Company and recent progress, including the commencement of the GLP pre-clinical trial, on Tuesday, September 13th at 2:30 p